Effect of Muscle Activation and Strength Training to Control Blood Sugar in Type II Diabetes patients
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2023/09/057825
- Lead Sponsor
- Vishwajeet Trivedi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Type 2 diabetic patients of 45 to 65 years.
Subjects with fasting blood glucose level < 250 mg / dl and > 100 mg / dl
Both males and females with type 2 diabetes will be recruited
Subject should not have any major systemic or diabetic complication.
Subjects who are on oral hypoglycemic drugs and not on insulin administration.
Subjects with low activity level as per IPAQ criteria. (Booth,2000)
Cooperative in nature and willing to participate in the study.
Subjects with type 1 Diabetes mellitus.
Using insulin/injections of any kind
Pregnant women
Physically active subjects.
Uncontrolled and fluctuating hypertension and blood glucose level
Previous myocardial infarction
Any other condition or history that might increase the risk to the individual or interfere with the study or the evaluation of data.
Cardiac arrhythmias
Non cooperative and unwilling subjects.
Use of metal implants, cardiac pacemakers or any other electrical device that are contraindicated for electrical stimulation.
Subjects who undergone any major surgical intervention.
Skin condition that may interfere with the delivery of the electrical stimulation.
Addicted to alcohol, smoking or drugs that interferes with the neuromuscular system.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood Glucose level, HbA1c, Basic Lipid profileTimepoint: At start of intervention, the end of 3-month intervention & after 3 months of intervention for follow-up
- Secondary Outcome Measures
Name Time Method Body weight, Heart rate, Blood Pressure, Body Composition, skin fold, Activity level, Functional Exercise Capacity, Adverse Effects, Changes in medication dose /use, food profile.Timepoint: At start of intervention, the end of 3-month intervention & after 3 months of intervention for follow-up